-TheWire.in The government should keep the secretary of the health department unchanged for three years for him/her to be able to show results. But that has not been happening. The NDA government had promised good governance and policy stability. Yet we have a fourth secretary in the health department in the last three years – the seventh in the last seven years. Since both the outgoing and the incoming officers have sterling...

-The Telegraph New Delhi: Health activists campaigning for affordable treatment on Wednesday urged the Narendra Modi government to resist "pressure" from foreign medical device makers and expand price caps to new classes of medical devices. The All India Drug Action Network (AIDAN), a consortium of non-government activists' groups, said it was concerned that a body of foreign medical device manufacturers had petitioned the US government seeking suspension or withdrawal of certain trade...

-The Hindu The former Attorney General about recent landmark judgments of the Supreme Court, the credibility of the court, and the sedition law Former Attorney General of India, Soli Sorabjee, was given the Padma Vibhushan 15 years back for his defence of the freedom of expression and protection of human rights. Now, at 87, Mr. Sorabjee says he is looking forward to making his arguments in a pending case on Aadhaar. Excerpts...

-IndiaTomorrow.net As a first step, SAMLA would run a nationwide movement with name of "Dalit, Minority, Tribal Lives Matter" New Delhi: In the wake of the growing culture of mob lynching and atrocities against religious minorities, Dalits and Tribals in the country, a group of lawyers on Tuesday launched a body to provide these communities with legal aid in order to get speedy justice. The body named as "South Asian Minorities Lawyers' Association"...

-The Telegraph New Delhi: India's drug pricing rules allow companies to inflate the maximum retail prices of medicines, including life-saving drugs, costing patients thousands of additional rupees while offering slices of the profits to stockists, chemists, and hospitals. Quotations received by hospitals from drug companies' representatives offering discounts on maximum retail prices (MRPs) of medicines provide what some doctors and patients' rights advocates say is fresh evidence for excessive profiteering in India's...